107 patients aged 60 or older, with trochanteric femoral fractures were treated with Proximal Femoral Nail Anti-rotation (PFNA) or Trochanteric Gamma nail (TGN) to determine a superior treatment in terms of functional outcome and complications. Patients were screened for age, gender, fracture classification, walking ability and American Society of Anesthesiologists (ASA) rating of operative risk- operative time, fluoroscope time, blood loss and any intra-operative complications were recorded. Patients were examined 3, 6, 12 months after the operation and yearly afterwards to determine any changes in the position of implant, complications or fixation failure- along with hip range of motion, pain about the hip and thighs, walking ability and return to work status. Patients treated with a PFNA demonstrated a shorter fluoroscopy time and less blood but no significant differences in terms of hospital stay, intra-operative and postoperative complications.